We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 2.

Figure 2. From: An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions.

Patient with stage IV pancreas adenocarcinoma and a BRCA1 mutation: Response to gemcitabine plus a poly(ADP-ribose) polymerase inhibitor.

Maeve A. Lowery, et al. Oncologist. 2011 October;16(10):1397-1402.
2.
Figure 1.

Figure 1. From: An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions.

Family pedigree of a patient with a BRCA1 mutation and pancreatic adenocarcinoma.
Note: Pedigree was altered to protect the confidentiality and privacy of family members without compromising relevant content.

Maeve A. Lowery, et al. Oncologist. 2011 October;16(10):1397-1402.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk